Literature DB >> 9535927

The mitogen-activated protein kinase phosphatase-3 N-terminal noncatalytic region is responsible for tight substrate binding and enzymatic specificity.

M Muda1, A Theodosiou, C Gillieron, A Smith, C Chabert, M Camps, U Boschert, N Rodrigues, K Davies, A Ashworth, S Arkinstall.   

Abstract

We have reported recently that the dual specificity mitogen-activated protein kinase phosphatase-3 (MKP-3) elicits highly selective inactivation of the extracellular signal-regulated kinase (ERK) class of mitogen-activated protein (MAP) kinases (Muda, M., Theodosiou, A., Rodrigues, N., Boschert, U., Camps, M., Gillieron, C., Davies, K., Ashworth, A., and Arkinstall, S. (1996) J. Biol. Chem. 271, 27205-27208). We now show that MKP-3 enzymatic specificity is paralleled by tight binding to both ERK1 and ERK2 while, in contrast, little or no interaction with either c-Jun N-terminal kinase/stress activated protein kinase (JNK/SAPK) or p38 MAP kinases was detected. Further study revealed that the N-terminal noncatalytic domain of MKP-3 (MKP-3DeltaC) binds both ERK1 and ERK2, while the C-terminal MKP-3 catalytic core (MKP-3DeltaN) fails to precipitate either of these MAP kinases. A chimera consisting of the N-terminal half of MKP-3 with the C-terminal catalytic core of M3-6 also bound tightly to ERK1 but not to JNK3/SAPKbeta. Consistent with a role for N-terminal binding in determining MKP-3 specificity, at least 10-fold higher concentrations of purified MKP-3DeltaN than full-length MKP-3 is required to inhibit ERK2 activity. In contrast, both MKP-3DeltaN and full-length MKP-3 inactivate JNK/SAPK and p38 MAP kinases at similarly high concentrations. Also, a chimera of the M3-6 N terminus with the MKP-3 catalytic core which fails to bind ERK elicits non selective inactivation of ERK1 and JNK3/SAPKbeta. Together, these observations suggest that the physiological specificity of MKP-3 for inactivation of ERK family MAP kinases reflects tight substrate binding by its N-terminal domain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9535927     DOI: 10.1074/jbc.273.15.9323

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase.

Authors:  Anindita Kar-Roy; Hasan Korkaya; Ruchi Oberoi; Sunil Kumar Lal; Shahid Jameel
Journal:  J Biol Chem       Date:  2004-04-19       Impact factor: 5.157

2.  Characterization of a novel low-molecular-mass dual specificity phosphatase-4 (LDP-4) expressed in brain.

Authors:  Kentaro Takagaki; Hiroshi Shima; Nobuhiro Tanuma; Miyuki Nomura; Takeshi Satoh; Masahiko Watanabe; Kunimi Kikuchi
Journal:  Mol Cell Biochem       Date:  2006-09-26       Impact factor: 3.396

Review 3.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

4.  Identification of a docking groove on ERK and p38 MAP kinases that regulates the specificity of docking interactions.

Authors:  T Tanoue; R Maeda; M Adachi; E Nishida
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

5.  The dual-specificity protein phosphatase DUSP9/MKP-4 is essential for placental function but is not required for normal embryonic development.

Authors:  Graham R Christie; David J Williams; Fiona Macisaac; Robin J Dickinson; Ian Rosewell; Stephen M Keyse
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  Characterization of a murine gene encoding a developmentally regulated cytoplasmic dual-specificity mitogen-activated protein kinase phosphatase.

Authors:  Robin J Dickinson; David J Williams; David N Slack; Jill Williamson; Ole-Morten Seternes; Stephen M Keyse
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

7.  The C.elegans MAPK phosphatase LIP-1 is required for the G(2)/M meiotic arrest of developing oocytes.

Authors:  Alex Hajnal; Thomas Berset
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

8.  Glucocorticoids induce rapid up-regulation of mitogen-activated protein kinase phosphatase-1 and dephosphorylation of extracellular signal-regulated kinase and impair proliferation in human and mouse osteoblast cell lines.

Authors:  Y Engelbrecht; H de Wet; K Horsch; C R Langeveldt; F S Hough; P A Hulley
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

9.  Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8.

Authors:  Xiuli Wu; Lily Yen; Lisa Irwin; Colleen Sweeney; Kermit L Carraway
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding.

Authors:  John K Mark; Rémy A Aubin; Sophie Smith; Mary Alice Hefford
Journal:  J Biol Chem       Date:  2008-08-11       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.